World News

New HIV Treatment, Antiretroviral Cabotegravir, Lasts For Three Months

Today, HIV infections are completely treatable thanks to antiretroviral medication. Only problem is these drugs must be taken on a regular basis for them to remain effective, and for many HIV-positive individuals throughout the world, this simply isn’t possible. A new antiretroviral drug called cabotegravir, however, may solve this widespread problem, since it only requires injection once every three months.

Scientists train immune system to spot and destroy cure-defying mutant HIV

Luring dormant HIV out of hiding and destroying its last cure-defying holdouts has become the holy grail of HIV eradication, but several recent attempts to do so have failed. Now the findings of a Johns Hopkins-led study reveal why that is and offer a strategy that could form a blueprint for a therapeutic vaccine to eradicate lingering virus from the body.

The surprising link between HIV and hearing loss

Adults who are HIV-positive are more likely to experience hearing loss than adults who do not have HIV, according to research published online December 26 in JAMA-Otolaryngology-Head & Neck Surgery. Researchers report that adults with HIV were more likely to experience difficulty hearing both high and low tones, regardless of the severity of HIV disease progression or the use of and adherence to HIV medications. Funded by the National Institutes of Health (NIH), the new findings expand upon earlier research that has suggested an increased risk of hearing loss in adults with HIV.

1 2 3 8